Výsledky vyhledávání - "Ole Østerberg"

Akademický článek

Burden of Medication Overuse in Migraine: A Cross-sectional, Population-Based Study in Five European Countries Using the 2020 National Health and Wellness Survey (NHWS)

Autor: Agnete Skovlund Dissing, Xin Ying Lee, Ole Østerberg, Lene Hammer-Helmich

Publikováno v: Neurology and Therapy, Vol 12, Iss 6, Pp 2053-2065 (2023)

Abstract Introduction Overuse of medication to treat migraine attacks can lead to development of a new type of headache or significant worsening of pre-existing headache, known as medication overuse headache. However, data concerning the burden of me

Externí odkaz: https://doaj.org/article/4446d96307454f948ba2580cc6c96553

Zobrazit plný text záznamu

Akademický článek

Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION—A phase 4, multinational, randomized, double-blind, placebo-controlled study

Autor: Rigmor H. Jensen, Henrik Winther Schytz, Cristina Tassorelli, Gisela M. Terwindt, Louise N. Carlsen, Aurélia Mittoux, Ole Østerberg, Richard B. Lipton, Stewart J. Tepper, Andrew Blumenfeld, Christofer Lundqvist

Publikováno v: Frontiers in Neurology, Vol 14 (2023)

IntroductionMigraine is a highly prevalent and disabling neurological disease. Excessive use of acute medications can lead to medication-overuse headache (MOH), occurring when a patient experiences an increasing number of headache and migraine days,

Externí odkaz: https://doaj.org/article/8522cd2252394345a8c40c52d7456c2f

Zobrazit plný text záznamu

Evaluating the clinical utility of the patient‐identified most bothersome symptom measure from PROMISE‐2 for research in migraine prevention

Autor: Richard B. Lipton, Peter J. Goadsby, David W. Dodick, James S. McGinley, Carrie R. Houts, R. J. Wirth, Steve Kymes, Anders Ettrup, Ole Østerberg, Roger Cady, Messoud Ashina, Dawn C. Buse

Publikováno v: Lipton, R B, Goadsby, P J, Dodick, D W, McGinley, J S, Houts, C R, Wirth, R J, Kymes, S, Ettrup, A, Østerberg, O, Cady, R, Ashina, M & Buse, D C 2022, ' Evaluating the clinical utility of the patient-identified most bothersome symptom measure from PROMISE-2 for research in migraine prevention ', Headache, vol. 62, no. 6, pp. 690-699 . https://doi.org/10.1111/head.14295

Objective: To assess the utility of the novel patient-identified (PI) most bothersome symptom (MBS) measure from PROMISE-2, a phase 3 trial of eptinezumab for the preventive treatment of chronic migraine. Background: Relief of bothersome migraine sym

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec6b416f2f359a039fef6af9fb3f2409
https://doi.org/10.1111/head.14295

Zobrazit plný text záznamu

Corrigendum to 'Brief international cognitive assessment for multiple sclerosis (BICAMS): A Danish validation study of sensitivity in early stages of MS' [Multiple Sclerosis and Related Disorders 37 (2020) 101458]

Autor: Karen Schreiber, Trine Walsted, Ole Østerberg, Lisbet Marstrand, Finn Sellebjerg, Amalie C. Skov

Publikováno v: Multiple sclerosis and related disorders. 38

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d87f47e4325def75cf0f25f67885881
https://pubmed.ncbi.nlm.nih.gov/31683230

Zobrazit plný text záznamu

NS11821, a partial subtype-selective GABA(A) agonist, elicits selective effects on the central nervous system in randomized controlled trial with healthy subjects

Autor: Rob Zuiker, Pierandrea Muglia, Joop M. A. van Gerven, Ole Østerberg, Naheed R. Mirza, Xia Chen, Erica S. Klaassen, Marieke de Kam

Publikováno v: Journal of Psychopharmacology, 30(3), 253-262

NS11821 is a partial GABAA agonist with relatively dominant α2,3 and α5 subtype efficacy but negligible α1 agonism. This first-in-human study was performed in healthy male subjects using a single-dose, parallel, double blind, placebo-controlled, r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a4832679d6bfce557668f6aaff3ac4b
https://hdl.handle.net/1887/112006

Zobrazit plný text záznamu

Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults

Autor: Ulrika S. H. Simonsson, Ole Østerberg, Mats O. Karlsson, Radojka M. Savic, Henrik Agersø, Johan Vande Walle, Jens Peter Nørgaard

Publikováno v: Journal of clinical pharmacology. 46(10)

The population pharmacokinetics of desmopressin in children with nocturnal enuresis and in healthy adults were compared using a 1-compartment model with first-order absorption and first-order elimination. In addition, the model consisted of a number

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c82fa6ac0f7c000184b0a53aa468034d
https://pubmed.ncbi.nlm.nih.gov/16988210

Zobrazit plný text záznamu

Pharmacokinetic and pharmacodynamic properties of insulin aspart and human insulin

Autor: Paolo Vicini, Ole Østerberg, Henrik E. Poulsen, Anne Plum, Steen H. Ingwersen, Lars Erichsen

Publikováno v: Journal of pharmacokinetics and pharmacodynamics. 30(3)

The preferred approach to determine the pharmacokinetic (PK) and pharmacodynamic (PD) properties of insulin analogues is the euglycemic glucose clamp. Currently non-compartmental data analytical approaches are used to analyze data. The purpose of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e57788f1c686a742240a20aa5d654c5
https://pubmed.ncbi.nlm.nih.gov/14571692

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání